ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
Retrieved on:
Monday, April 3, 2023
Systematic review, 10A, Surgeon, Health Insurance Fund, Physician, National Health Insurance Fund, Republic, Motion, Patient, JORF, Biomedical text mining, United Kingdom, National Institute for Health and Care Excellence, FDA, WHO model list of essential in vitro diagnostics, LPP, News, NICE, Medical device, Health
In addition, the clinical data for Mobi-C was awarded the highest quality rating of 10A* by the Orthopaedic Data Evaluation Panel in the United Kingdom.
Key Points:
- In addition, the clinical data for Mobi-C was awarded the highest quality rating of 10A* by the Orthopaedic Data Evaluation Panel in the United Kingdom.
- “This reimbursement of the Mobi-C prosthesis is really excellent news.
- ODEP provides the objective, systematic review and rating of the strength of evidence supporting the performance of medical devices.
- “We applaud the French reimbursement decision for Mobi-C and welcome the exemplary 10A* rating from ODEP,” said Rebecca Whitney, Global President of ZimVie Spine.